Stockreport

ALX Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

ALX Oncology Holdings Inc.  (ALXO) 
PDF SOUTH SAN FRANCISCO, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., (“ALX Oncology” or “the Company”) (Nasdaq: ALXO), an immuno-oncology compan [Read more]